enGene's Series A - II Round

enGene raised a round of funding on August 03, 2013. Investors include Lumira Ventures.

enGene is a Canadian biotechnology company developing an innovative mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease (IBD) and diabe…

Articles about enGene's Series A - II Round: